8 results match your criteria: "From Eastern Virginia Medical School[Affiliation]"

Emerging Insights in Keloid Pathogenesis and Therapeutics.

Cutis

November 2024

Noelle Desir is from Weill Cornell Medical College, New York, New York. Iain Noel Encarnacion is from Eastern Virginia Medical School, Norfolk. Dr. Taylor is from the Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

View Article and Find Full Text PDF

Painful Anal Lesions in a Patient With HIV.

Cutis

July 2024

Ryan C. Saal is from Eastern Virginia Medical School, Norfolk. Drs. Bramson, Miedema, and Mackow are from the University of North Carolina School of Medicine, Chapel Hill; Drs. Bramson and Mackow are from the Department of Infectious Disease, and Dr. Miedema is from the Department of Dermatology.

View Article and Find Full Text PDF

The CROWNing Event on Hair Loss in Women of Color: A Framework for Advocacy and Community Engagement (FACE) Survey Analysis.

Cutis

October 2022

Dr. Hobbs is from the University of Virginia School of Medicine, Charlottesville. Mr. Brown and Dr. Smith are from Eastern Virginia Medical School, Norfolk. Dr. Smith is from the Department of Dermatology. Mr. Brown also is from the Raymond A. Mason School of Business, College of William & Mary, Williamsburg, Virginia. Dr. Salkey is from the Virginia Commonwealth University Health System, Richmond. Dr. Harvey is from the Hampton University Skin of Color Research Institute, Virginia, and the Tidewater Physicians Multispecialty Group, Newport News, Virginia.

Hair loss is a primary reason for women with skin of color to seek dermatologic care. In addition to physical disfigurement, patients with hair loss are more likely to report feelings of depression, anxiety, and low self-esteem. There is a critical gap in dermatology advocacy efforts and educational information intended for women with skin of color.

View Article and Find Full Text PDF

Management of a Child vs an Adult Presenting With Acral Lesions During the COVID-19 Pandemic: A Practical Review.

Cutis

March 2021

Ms. Clawson is from Eastern Virginia Medical School, Norfolk. Dr. Tabata is from the Department of Internal Medicine, Massachusetts General Hospital, Boston. Dr. Ko is from the Department of Dermatology, Stanford University, California.

During the coronavirus disease 2019 (COVID-19) pandemic, there has been a rise in the diagnosis of acral lesions, including chilblains-like lesions, ischemia, and retiform purpura. Understanding the differences in presentation and severity of illness between children and adult patients is important for physicians to understand risk stratification and management of these lesions. We reviewed the literature on the acral lesions seen in children and adults with COVID-19 infection to offer guidelines for diagnosis and treatment.

View Article and Find Full Text PDF

Systemic lupus erythematosus is a chronic inflammatory condition caused by an autoimmune disease. Systemic lupus erythematosus has been described as inducing neuropsychiatric symptoms, including mania and psychosis, in approximately 14 to 80 percent of systemic lupus erythematosus patients. We present and discuss the differential diagnoses in a patient with mania and systemic lupus erythematosus being treated with immunosuppresants and also with a history of glucose-6-phosphate dehydrogenase deficiency.

View Article and Find Full Text PDF